Frontiers in Technology

(1000-A) A dynamic scheduling method for autonomous maintenance of human iPS cells without human intervention.

(1001-B) Assessing critical quality attributes of cell identity, count, and viability for cell therapy development using the high-throughput Cellaca PLX image cytometer

(1003-B) Automated and miniaturized 13C-isotopic labeling experiments in microtiter plate scale

(1004-A) A perfused 3D model of the human blood-brain barrier in the OrganoPlate®

(1005-B) Automation of host cell protein analysis by mass spectrometry: Increased speed and reproducibility, from sample preparation to report

(1009-B) Do-it-yourself kit for laboratory automation using the example of a media exchange for an organoid culture

(1011-B) High throughput contactless volume verification for high density microtiter plates and microarrays

(1012-A) The Future is Here: Automation demonstrates its value as a precision tool for accelerating drug discovery

(1015-B) Increased throughput, walk-away time and efficiency with Tecan automated cIEF sample preparation

(1017-B) Long-term proliferation arrayed CRISPR screening by colour competition assay at scale

(1021-B) Spectral Shift & MST-TRIC: New Biophysical Technologies Supporting Kinase Drug Discovery Programs

(1023-B) Unambiguous Reproduction of Chemical Protocols using a Chemical Description Language on General Robotic Synthesis Hardware

(1026-A) Automated nanoliter droplet selection and collection device for micro droplet arrays

(1029-B) Towards robotic laboratory automation Plug & Play: The “LAPP” framework

(1033-B) High throughput rapid sintering and dielectric characterization of ferroelectrics predicted by machine learning

(1034-A) Improving Assay Optimisation and Pharmacological Sensitivity of a Nuclease Target by Employing a Computer-aided Biology Approach

(1035-B) Miniaturisation of an Aqueous Solubility assay using Acoustic Dispensing and 384-Well Based Workflows

(1037-B) Construction of a quantitative evaluation system for cell culture operation and cellular condition with a versatile humanoid robot

(1039-B) ot2eye: Detection of labware conditions to monitor and extend affordable liquid-handling robots

(1044-A) A high throughput TEER measurement device for on-chip tissue barrier assessment

(1045-B) A highly automated microscopy analytics pipeline for high-throughput organ-on-chip platforms

(1047-B) A Minimal Open-Access Platform for Laboratory Automation Training

(1050-A) AI-enabled Novel Workflow to Evaluate T-Cell activity in vitro Using 3D Spheroid Models

(1051-B) An Innovative Cell Culture Platform that Enables the Generation of Thousands of Three-Dimensional Cultures in One Flask

(1054-A) Automated 3D Cell-Based Assays in Animal-Free Nanofibrillar Cellulose Hydrogels for High-Throughput Screening

(1055-B) Automated In Vitro MDCKII-BCRP Monolayer Assay with Ultra-Fast LC-MS/MS

(1056-A) Automated workflow from sample lysis to amplification for rapid SARS-CoV-2 detection

(1057-B) Automating Analytical

(1058-A) Automation of 3D bioprinting assays for high-content imaging and assessment of compound effects

(1065-B) Continued development of high throughput MS within AstraZeneca’s Discovery Sciences

(1066-A) Developing comprehensive digital twins of research laboratories: Introducing a systems engineering approach

(1071-B) Exploring the Landscape of PARP Inhibitor Selectivity in Live Cells Using NanoBRET™ Target Engagement Assays

(1074-A) Full automated qPCR for small molecule screening of RNA targets

(1076-A) High content imaging is now high throughput: End to end high content imaging and analysis of autophagy on a subcellular level in minutes

(1077-B) High Content Phenotypic Screening of Cell Paint Assays on Araceli Endeavor

(1078-A) High throughput characterization of advanced 3D liver models for in vitro hepatotoxicity studies

(1082-A) Kinome Profiling with Continuous Assays and Integration of Automated Linear Range Determination to Accelerate Generation of Improved Drug Treatments

(1084-A) Learning from the JUMP CP pilot data: Insights for platform development

(1085-B) Multiplexing Enzyme Reactions Using RapidFire Mass Spectrometry

(1024-A) NanoBRET Approach for Characterizing the Impact of RAS Pathway Inhibitors on Protein Interactions in Live Cells

(1088-A) New non-toxic dye to probe cell physiology in high content screening

(1089-B) NOMAD® biosensors for multiplexing Ca2+ and b-Arrestin functional assays of Proteinase-activated receptor 2 (PAR2)

(1092-A) Riding the Calcium Wave: High-Throughput Insights from Spontaneous and Induced Ca2+ Oscillations using Relevant iPSC-based Models

(1093-B) Simple Western with Jess is even more simple with CyBio FeliX Liquid Handling

(1097-B) SYNTAX system enables rapid probe synthesis and testing to accelerate custom qPCR assay development

(1102-A) Unlocking Targeted Protein Degradation

(1103-B) Utilising a fully integrated automation platform to enable high-throughput arrayed CRISPR editing for novel target identification